Empire Financial Management Company, LLC Biocryst Pharmaceuticals Inc Transaction History
Empire Financial Management Company, LLC
- $325 Billion
- Q3 2024
A detailed history of Empire Financial Management Company, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Empire Financial Management Company, LLC holds 59,000 shares of BCRX stock, worth $509,170. This represents 0.14% of its overall portfolio holdings.
Number of Shares
59,000
Previous 59,000
-0.0%
Holding current value
$509,170
Previous $365 Million
22.98%
% of portfolio
0.14%
Previous 0.12%
Shares
6 transactions
Others Institutions Holding BCRX
# of Institutions
286Shares Held
171MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA21.9MShares$189 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$172 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$102 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$78.4 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$76.4 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.6B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...